BSE: AUROPHARMA - Aurobindo Pharma Limited

Доходность за полгода: -15.7%

График акции Aurobindo Pharma Limited

Расширенный график Простой график
Financial Markets by TradingView

О компании

Aurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally.

подробнее
The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Добавить в список сравнения
Добавить в список отслеживания
Добавить в портфель
Добавить уведомление о цене

ISIN INE406A01037
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.7306
Дивиденд ао 4.5
Сайт https://www.aurobindo.com
Цена ао 1161.85
Изменение цены за день: -0.4734% (1161.85)
Изменение цены за неделю: -10.79% (1296.15)
Изменение цены за месяц: -4.27% (1207.95)
Изменение цены за 3 месяца: -21.86% (1479.8)
Изменение цены за полгода: -15.7% (1371.7)
Изменение цены за год: +0.5522% (1150)
Изменение цены за 3 года: +61.19% (717.4)
Изменение цены за 5 лет: +156.88% (450.15)
Изменение цены за 10 лет: 0% (1156.35)
Изменение цены с начала года: -6.8% (1240.7)
Все параметры

Недооценка

Название Значение Оценка
P/S 2.08 7
P/BV 2 7
P/E 18.84 7
EV/EBITDA 7.61 9
Итого: 6.88

Эффективность

Название Значение Оценка
ROA, % 7.47 2
ROE, % 11.2 4
Итого: 3.33

Дивиденды

Название Значение Оценка
Div yield, % 0.7306 1.83
DSI 0.8571 8.57
Итого: 1.99

Долг

Название Значение Оценка
Debt/EBITDA 1.58 7
Итого: 8.4

Импульс роста

Название Значение Оценка
Доходность Revenue, % 26.24 4
Доходность Ebitda, % 2.24 1
Доходность EPS, % 12.08 2
Итого: 1.8
Подробнее

ETF Доля, % Доходность за год, % Дивиденды, %
Fidelity Emerging Markets Multifactor ETF 1.65455 9.3 4.83083
VictoryShares Emerging Markets Value Momentum ETF 0.94165 13.66 4.52229
Invesco S&P Emerging Markets Momentum ETF 0.56274 18.98 2.50979
Hartford Multifactor Emerging Markets ETF 0.53562 11.21 5.04734
WisdomTree Emerging Markets Multifactor Fund 0.50144 16.97 3.61297
WisdomTree India Earnings Fund 0.33497 5.23 1.65591
iShares MSCI India ETF 0.29108 3.5 1.24292
Dimensional Emerging Markets Value ETF 0.28877 17.07 4.19508
Franklin FTSE India ETF 0.25957 20.52 1.25133
Avantis Emerging Markets Value ETF 0.23119 14.12 4.22231
Avantis Responsible Emerging Markets Equity ETF 0.19961 17.6 3.1719
KraneShares MSCI Emerging Markets ex China Index ETF 0.19853 11.18 3.46245
SPDR MSCI Emerging Markets Fossil Fuel Free ETF 0.19628 14.02 2.84808
JPMorgan Diversified Return Emerging Markets Equity ETF 0.12768 7.2 5.1761
Goldman Sachs ActiveBeta Emerging Markets Equity ETF 0.12742 9.13 3.47133
iShares MSCI BIC ETF 0.12324 14.55 2.77084
SPDR Portfolio Emerging Markets ETF 0.10941 11.59 3.1879
iShares MSCI Emerging Markets Min Vol Factor ETF 0.10671 6.61 2.95411
Avantis Emerging Markets Equity ETF 0.08535 8.77 3.60513
WisdomTree Emerging Markets Efficient Core Fund 0.07784 17.03 3.08497
iShares MSCI Emerging Markets Asia ETF 0.0759 13.87 2.40119
Dimensional Emerging Markets Core Equity 2 ETF 0.06949 15.96 3.34087
John Hancock Multifactor Emerging Markets ETF 0.0674 4.68 3.42078
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF 0.0633 2.43 4.35382
Franklin FTSE Asia ex Japan ETF 0.0631 14.43 2.66768
Xtrackers MSCI Emerging Markets Hedged Equity ETF 0.05497 15.84 3.04307
SPDR MSCI Emerging Markets StrategicFactors ETF 0.0478 8.65 3.55491
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund 0.04449 12.46 3.59676
Dimensional World ex U.S. Core Equity 2 ETF 0.03598 13.06 3.62488
SPDR MSCI ACWI ex-US ETF 0.0325 7.85 3.3217
Vanguard ESG International Stock ETF 0.02 6.39 3.07501
iShares Core MSCI Total International Stock ETF 0.01792 6.4 3.25258
Xtrackers MSCI All World ex US Hedged Equity ETF 0.01686 18.18 3.26685
iShares MSCI ACWI ETF 0.00474 -19.68 2.10908

Руководитель Должность Оплата Год рождения
Mr. Mettu Madan Mohan Reddy Whole-Time Director 52.35M 1960 (65 лет)
Mr. Santhanam Subramanian Chief Financial Officer 21.06M 1961 (64 года)
Mr. Sanjeev Indravadan Dani COO & Head of Formulations N/A 1960 (65 лет)
Dr. S. Vijaya Kumar President of Technical N/A 1966 (59 лет)
Mr. Arvind Bothra Head of Investor Relations & Corporate Communications N/A
Mr. B. Adi Reddy Compliance Officer & Company Secretary 4.76M
Mr. G. P. Prasad Senior Vice President of Global Finance & Operations N/A
Dr. Sudhir Bimal Singhi Head of Global Finance Operations N/A 1969 (56 лет)
Mr. Kambam Nithyananda Reddy Vice Chairman & MD 1958 (67 лет)
Dr. Makkapati Satakarni B.E., M.B.A., Ph.D. President of Biologics, CEO of Biologics, Vaccines and Peptid & Director 1981 (44 года)

Адрес: India, Hyderabad, Galaxy Plot No. 1 - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.aurobindo.com